Ta grade 3/high grade non-invasive bladder cancer: Should we perform a second TUR?

TİNAY, İLKER; Baltaci, Sumer; Demirdag, ÇETİN; AKDOĞAN, BÜLENT; Yucetas, Ugur; Simsekoglu, MUHAMMED; Haberal, Hakan; Bozlu, Murat; İZOL, VOLKAN; Aslan, Guven; Bekiroglu, Nural

doi:10.1111/ijcp.13924

Ta grade 3/high grade non-invasive bladder cancer: Should we perform a second TUR?

TİNAY İ., Baltaci S., Demirdag Ç., AKDOĞAN B., Yucetas U., Simsekoglu M. F., ...Daha Fazla

INTERNATIONAL JOURNAL OF CLINICAL PRACTICE, cilt.75, sa.4, 2021 (SCI-Expanded, Scopus)

Yayın Türü: Makale / Tam Makale
Cilt numarası: 75 Sayı: 4
Basım Tarihi: 2021
Doi Numarası: 10.1111/ijcp.13924
Dergi Adı: INTERNATIONAL JOURNAL OF CLINICAL PRACTICE
Derginin Tarandığı İndeksler: Science Citation Index Expanded (SCI-EXPANDED), Scopus, Agricultural & Environmental Science Database, CAB Abstracts, CINAHL, EMBASE, International Pharmaceutical Abstracts, MEDLINE
İstanbul Üniversitesi-Cerrahpaşa Adresli: Evet

Özet

Purpose To evaluate the effect of second transurethral resection (TUR) on oncological outcomes, according to the presence or absence of detrusor muscle in the initial TUR of patients with pTa Grade 3/high grade (G3/HG) tumours, who received at least 1 year of maintenance Bacillus Calmette-Guerin (BCG) therapy.